Additional file 3: of Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

Inoue, Yuzaburo; Mitsunaga, Kanako; Yamamoto, Takeshi; Chiba, Koki; Yamaide, Fumiya; Nakano, Taiji; Morita, Yoshinori; Yamaide, Akiko; Suzuki, Shuichi; Arima, Takayasu; Yamaguchi, Ken-ichi; Tomiita, Minako; Shimojo, Naoki; Kohno, Yoichi

doi:10.6084/m9.figshare.6599786.v1

12969_2018_258_MOESM3_ESM.docx (26.01 kB)

Additional file 3: of Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

journal contribution

posted on 2018-06-18, 05:00 authored by Yuzaburo Inoue, Kanako Mitsunaga, Takeshi Yamamoto, Koki Chiba, Fumiya Yamaide, Taiji Nakano, Yoshinori Morita, Akiko Yamaide, Shuichi Suzuki, Takayasu Arima, Ken-ichi Yamaguchi, Minako Tomiita, Naoki Shimojo, Yoichi Kohno

Table S3. The characteristics and outcomes of alendronate-treated patients with and without bone loss. (DOCX 26 kb)